These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22273505)

  • 1. Mechanisms of FGFR-mediated carcinogenesis.
    Ahmad I; Iwata T; Leung HY
    Biochim Biophys Acta; 2012 Apr; 1823(4):850-60. PubMed ID: 22273505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated FGF signalling in neoplastic disorders.
    Tanner Y; Grose RP
    Semin Cell Dev Biol; 2016 May; 53():126-35. PubMed ID: 26463732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
    Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
    J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges in targeting FGFR signalling in cancer.
    Babina IS; Turner NC
    Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors.
    Li Y; Basilico C; Mansukhani A
    Mol Cell Biol; 1994 Nov; 14(11):7660-9. PubMed ID: 7935480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.
    Liu G; Chen T; Ding Z; Wang Y; Wei Y; Wei X
    Cell Prolif; 2021 Apr; 54(4):e13009. PubMed ID: 33655556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF/FGFR signaling in bone formation: progress and perspectives.
    Marie PJ; Miraoui H; Sévère N
    Growth Factors; 2012 Apr; 30(2):117-23. PubMed ID: 22292523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of fibroblast growth factor receptors in carcinogenesis.
    Haugsten EM; Wiedlocha A; Olsnes S; Wesche J
    Mol Cancer Res; 2010 Nov; 8(11):1439-52. PubMed ID: 21047773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor signalling: from development to cancer.
    Turner N; Grose R
    Nat Rev Cancer; 2010 Feb; 10(2):116-29. PubMed ID: 20094046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
    Carter EP; Fearon AE; Grose RP
    Trends Cell Biol; 2015 Apr; 25(4):221-33. PubMed ID: 25467007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
    Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
    Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-regulated FGF receptors as therapeutic targets in cancer.
    Knights V; Cook SJ
    Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical fibroblast growth factor signalling in angiogenesis.
    Murakami M; Elfenbein A; Simons M
    Cardiovasc Res; 2008 May; 78(2):223-31. PubMed ID: 18056763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
    Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.